What is the market doing?
What the tape says about IDYA
IDEAYA Biosciences, Inc. is +86% over the past year while the S&P 500 is +23%: 63 points ahead of the market.
+86%
1-year return · S&P 500 +23%
- vs 200-day average
- +26%
vs 200-day average · a clear uptrend
- RSI (14)
- 80
RSI (14) · overbought, bought harder than it has been sold
- Below its 52-week high
- −2.1%
Below its 52-week high
Details›
- Last close2026-08-26
- $41.59
- 1 monthS&P 500 +3.7%
- +15%
- 1 yearS&P 500 +23%
- +86%
- 5 yearsS&P 500 +87%
- +77%
- vs 50-day average$34.64
- +20%
- 52-week high
- $42.48
- 52-week low
- $22.84
- Annualised volatility
- 50%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- $1.6M
| Year | Return |
|---|---|
| 2026 (year to date) | +20% |
| 2025 | +35% |
| 2024 | −28% |
| 2023 | +96% |
| 2022 | −23% |
| 2021 | +69% |
| 2020 | +87% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 7 | 3 of 7 | +1.9% |
| Feb | 7 | 4 of 7 | −5.6% |
| Mar | 7 | 2 of 7 | −11% |
| Apr | 7 | 3 of 7 | +6.2% |
| May | 7 | 4 of 7 | +15% |
| Jun | 8 | 6 of 8 | +11% |
| Jul | 8 | 4 of 8 | +2.3% |
| Aug | 8 | 3 of 8 | −0.95% |
| Sep | 7 | 5 of 7 | +11% |
| Oct | 7 | 3 of 7 | −5.2% |
| Nov | 7 | 6 of 7 | +12% |
| Dec | 7 | 4 of 7 | +1.7% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.